DOI QR코드

DOI QR Code

Single-cell RNA sequencing identifies distinct transcriptomic signatures between PMA/ionomycin- and αCD3/αCD28-activated primary human T cells

  • Jung Ho Lee (Department of Biomedical Sciences, Seoul National University Graduate School) ;
  • Brian H Lee (Department of Biomedical Sciences, Seoul National University Graduate School) ;
  • Soyoung Jeong (Department of Biomedical Sciences, Seoul National University Graduate School) ;
  • Christine Suh-Yun Joh (Department of Biomedical Sciences, Seoul National University Graduate School) ;
  • Hyo Jeong Nam (Department of Biomedical Sciences, Seoul National University Graduate School) ;
  • Hyun Seung Choi (Department of Biomedical Sciences, Seoul National University Graduate School) ;
  • Henry Sserwadda (Department of Biomedical Sciences, Seoul National University Graduate School) ;
  • Ji Won Oh (Department of Anatomy, Yonsei University College of Medicine) ;
  • Chung-Gyu Park (Department of Biomedical Sciences, Seoul National University Graduate School) ;
  • Seon-Pil Jin (Department of Dermatology, Seoul National University Hospital) ;
  • Hyun Je Kim (Department of Biomedical Sciences, Seoul National University Graduate School)
  • Received : 2023.02.09
  • Accepted : 2023.04.03
  • Published : 2023.06.30

Abstract

Immunologists have activated T cells in vitro using various stimulation methods, including phorbol myristate acetate (PMA)/ionomycin and αCD3/αCD28 agonistic antibodies. PMA stimulates protein kinase C, activating nuclear factor-κB, and ionomycin increases intracellular calcium levels, resulting in activation of nuclear factor of activated T cell. In contrast, αCD3/αCD28 agonistic antibodies activate T cells through ZAP-70, which phosphorylates linker for activation of T cell and SH2-domain-containing leukocyte protein of 76 kD. However, despite the use of these two different in vitro T cell activation methods for decades, the differential effects of chemical-based and antibody-based activation of primary human T cells have not yet been comprehensively described. Using single-cell RNA sequencing (scRNA-seq) technologies to analyze gene expression unbiasedly at the single-cell level, we compared the transcriptomic profiles of the non-physiological and physiological activation methods on human peripheral blood mononuclear cell-derived T cells from four independent donors. Remarkable transcriptomic differences in the expression of cytokines and their respective receptors were identified. We also identified activated CD4 T cell subsets (CD55+) enriched specifically by PMA/ionomycin activation. We believe this activated human T cell transcriptome atlas derived from two different activation methods will enhance our understanding, highlight the optimal use of these two in vitro T cell activation assays, and be applied as a reference standard when analyzing activated specific disease-originated T cells through scRNA-seq.

Keywords

Acknowledgement

This work was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT (2022M3A9D3016848), and by the Basic Science Research Program through the National Research Foundation (NRF) funded by the Ministry of Education (2020R1F1A1073692 and 2022R1F1A1075235).

References

  1. Chan AC, Iwashima M, Turck CW, Weiss A. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell 1992;71:649-662. https://doi.org/10.1016/0092-8674(92)90598-7
  2. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 1998;92:83-92. https://doi.org/10.1016/S0092-8674(00)80901-0
  3. Koretzky GA, Abtahian F, Silverman MA. SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond. Nat Rev Immunol 2006;6:67-78. https://doi.org/10.1038/nri1750
  4. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993;11:191-212. https://doi.org/10.1146/annurev.iy.11.040193.001203
  5. Matsumoto R, Wang D, Blonska M, Li H, Kobayashi M, Pappu B, et al. Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation. Immunity 2005;23: 575-585. https://doi.org/10.1016/j.immuni.2005.10.007
  6. Iezzi G, Karjalainen K, Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 1998;8:89-95. https://doi.org/10.1016/S1074-7613(00)80461-6
  7. La Gruta NL, Liu H, Dilioglou S, Rhodes M, Wiest DL, Vignali DA. Architectural changes in the TCR:CD3 complex induced by MHC:peptide ligation. J Immunol 2004;172:3662-3669. https://doi.org/10.4049/jimmunol.172.6.3662
  8. Suhoski MM, Golovina TN, Aqui NA, Tai VC, Varela-Rohena A, Milone MC, et al. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol Ther 2007;15:981-988. https://doi.org/10.1038/mt.sj.6300134
  9. Lawlor N, Nehar-Belaid D, Grassmann JD, Stoeckius M, Smibert P, Stitzel ML, et al. Single cell analysis of blood mononuclear cells stimulated through either LPS or anti-CD3 and anti-CD28. Front Immunol 2021;12:636720.
  10. El Hentati FZ, Gruy F, Iobagiu C, Lambert C. Variability of CD3 membrane expression and T cell activation capacity. Cytometry B Clin Cytom 2010;78:105-114. https://doi.org/10.1002/cyto.b.20496
  11. Liu H, Rhodes M, Wiest DL, Vignali DA. On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity 2000;13:665-675. https://doi.org/10.1016/S1074-7613(00)00066-2
  12. Jiao J, Zhao X, Hou R, Wang Y, Chang W, Liang N, et al. Comparison of two commonly used methods for stimulating T cells. Biotechnol Lett 2019;41:1361-1371. https://doi.org/10.1007/s10529-019-02743-w
  13. Olsen I, Sollid LM. Pitfalls in determining the cytokine profile of human T cells. J Immunol Methods 2013;390:106-112. https://doi.org/10.1016/j.jim.2013.01.015
  14. Dong C. Cytokine regulation and function in T cells. Annu Rev Immunol 2021;39:51-76. https://doi.org/10.1146/annurev-immunol-061020-053702
  15. Han S, Tie X, Meng L, Wang Y, Wu A. PMA and ionomycin induce glioblastoma cell death: activation-induced cell-death-like phenomena occur in glioma cells. PLoS One 2013;8:e76717.